Panacea Biotec Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 1,430.2 million compared to INR 1,051.2 million a year ago. Revenue was INR 1,462.5 million compared to INR 1,155.7 million a year ago. Net loss was INR 82.9 million compared to net income of INR 157 million a year ago. Basic loss per share from continuing operations was INR 1.35 compared to basic earnings per share from continuing operations of INR 2.56 a year ago.
For the six months, sales was INR 2,722.1 million compared to INR 2,158.2 million a year ago. Revenue was INR 2,815.2 million compared to INR 2,384.8 million a year ago. Net income was INR 26.9 million compared to net loss of INR 404.4 million a year ago. Basic earnings per share from continuing operations was INR 0.44 compared to basic loss per share from continuing operations of INR 6.6 a year ago.